NCT02642042

Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2016-07-18Est. Completion: 2019-05-15

Enrollment target: 60 participants

Locations

Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
Alaska Women's Cancer Care, Anchorage, Alaska, United States
Anchorage Oncology Centre, Anchorage, Alaska, United States
Katmai Oncology Group, Anchorage, Alaska, United States
Providence Alaska Medical Center, Anchorage, Alaska, United States
CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States
PCR Oncology, Arroyo Grande, California, United States
Sutter Auburn Faith Hospital, Auburn, California, United States
Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield, California, United States
Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States

Metastatic Colorectal CancerCRCKRAS/NRAS Mutation

The purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effe…

Phoenix, United StatesEst. completion Nov 2026

Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia (CMML) is the most frequent of myelodysplastic/myeloproliferative syndromes, as defined …

Nice, FranceEst. completion Nov 5, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.